Skip to main content
Clinical Trials/IRCT20230914059430N2
IRCT20230914059430N2
Completed
Phase 2

The rate of osteopenia of prematurity in premature infants who received caffeine prophylaxis in the neonatal intensive care unit: a clinical trial

Tehran University of Medical Sciences0 sites38 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Osteopenia of prematurity.
Sponsor
Tehran University of Medical Sciences
Enrollment
38
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Infants with a fetal age of less than 32 weeks
  • Infants who had spontaneous breathing

Exclusion Criteria

  • Neonates with major congenital anomalies
  • Asphyxiation
  • Hypoxic Ischemic Encephalopathy stage 2 , 3
  • Intrauterine growth retardation
  • Neonates with cholestasis
  • Neonates with neuromuscular disease

Outcomes

Primary Outcomes

Not specified

Similar Trials